Per-Olov Eriksson

Per-Olov Eriksson is a Process Development Scientist by training, focusing on heparin, LMWH and derivatives thereof as well as recombinant proteins, MaBs development and their manufacturing. He has 30 years of experience from the pharmaceutical industry and was Director of Process Development at Pharmacia and at Esperion Therapeutics Inc, both in USA. He has broad experience in heparin and LMWH manufacturing, where he led the startup of the facility for Fragmin production and continued to work with heparin process development and production. Per-Olov is a Co-founder of Dilafor.